Abstract
Background
The purpose of this retrospective study was to test whether the pretreatment hematologic profile can predict the prognosis of patients with head and neck cancer.
Methods
Medical records from 278 patients with head and neck cancer were reviewed, and 270 cases were evaluable. Clinical data including age, gender, stage, pretreatment hematologic profile (including white blood cell, platelet, and differential counts, and hemoglobin level) were recorded. Statistical analyses were performed to determine the prognostic effect of these hematologic indicators, as well as clinical variables. The association between the hematologic indicators and clinical factors was also analyzed.
Results
Pretreatment monocytes >1,000 cells/μl (P = 0.028), hemoglobin <11.0 g/dl (P = 0.022), and platelet count >400 × 103 cells/μl (P = 0.017) were identified as independent prognostic factors in addition to the nodal status and metastasis. A significant correlation between T-stage/monocyte or platelet count and metastasis/platelet count were shown. Monocytosis, anemia, and thrombocytosis were demonstrated to have a cumulative effect on the prognosis of head and neck cancer patients (normal vs. abnormality in one lineage, P = 0.001; abnormality in one vs. more than one lineage, P = 0.005).
Conclusions
A pretreatment hematologic profile can be considered as a useful prognostic marker in patients with head and neck cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13:193–205. doi:10.1016/j.ccr.2007.11.032
Baghi M, Wagenblast J, Hambek M, Moertel S, Gstoettner W, Strebhardt K, Knecht R (2008) Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clin Otolaryngol 33:245–251. doi:10.1111/j.1749-4486.2008.01702.x
Becker A, Stadler P, Lavey RS, Hänsgen G, Kuhnt T, Lautenschläger C, Feldmann HJ, Molls M, Dunst J (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46:459–466. doi:10.1016/S0360-3016(99)00384-3
Brockmann MA, Giese A, Mueller K et al (2007) Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro-oncol 9:335–342. doi:10.1215/15228517-2007-013
Caro JJ, Salas M, Ward A et al (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91:2214–2221. doi:10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
Chen CC, Chang JY, Liu KJ et al (2005) Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Ann Oncol 16:988–989. doi:10.1093/annonc/mdi171
Cox DR (1972) Regression models and life tables. J R Stat Soc Ser 34:187–220
De Palma M, Venneri MA, Roca C et al (2003) Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9:789–795. doi:10.1038/nm871
Department of Health (2004) The Executive Yuan cancer registry annual report in Taiwan area. Department of Health, ExecutiveYuan, ROC
Dirkx AE, Oude Egbrink MG, Wagstaff J et al (2006) Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 80:1183–1196. doi:10.1189/jlb.0905495
Dunst J, Kuhnt T, Strauss HG et al (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56:778–787. doi:10.1016/S0360-3016(03)00123-8
Gogus C, Baltaci S, Filiz E et al (2004) Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 63:447–450. doi:10.1016/j.urology.2003.10.039
Greene FL, Leslie HS (2008) The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 58:180–190. doi:10.3322/CA.2008.0001
Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Hockel M, Schlenger K, Mitze M et al (1996) Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6:3–9. doi:10.1016/S1053-4296(96)80031-2
Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287–291
Kasuga I, Makino S, Kiyokawa H et al (2001) Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 92:2399–2405. doi:10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612. doi:10.1158/0008-5472.CAN-05-4005
Lu CC, Chang KW, Chou FC et al (2007) Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol 43:283–288. doi:10.1016/j.oraloncology.2006.03.010
Lyden D, Hattori K, Dias S et al (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194–1201. doi:10.1038/nm1101-1194
Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U et al (2007) Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 380:208–212. doi:10.1016/j.cca.2007.02.037
Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153–156. doi:10.1002/ijc.1440
Patruno R, Arpaia N, Gadaleta CD et al (2008) VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med 13:555–561. doi:10.1111/j.1582-4934.2008.00355.x
Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9:1826–1830. doi:10.1183/09031936.96.09091826
Pedersen LM, Milman N (2003) Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 10:213–216
Peto R, Pike MC (1973) Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 29:579–584. doi:10.2307/2529177
Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78. doi:10.1038/nrc1256
Rades D, Schild SE, Bahrehmand R et al (2005) Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels. Cancer 103:1740–1746. doi:10.1002/cncr.20952
Rudat V, Dietz A, Schramm O et al (1999) Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 53:119–125. doi:10.1016/S0167-8140(99)00119-X
Shimada H, Oohira G, Okazumi S et al (2004) Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198:737–741. doi:10.1016/j.jamcollsurg.2004.01.022
Sugitani I, Kasai N, Fujimoto Y et al (2001) Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 25:617–622. doi:10.1007/s002680020166
Suzuki K, Aiura K, Kitagou M et al (2004) Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology 51:847–853
Taucher S, Salat A, Gnant M et al (2003) Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89:1098–1106
Uemura Y, Kobayashi M, Nakata H et al (2006) Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways. Int J Mol Med 18:365–373
Van Belle SJ, Cocquyt V (2003) Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol 47:1–11. doi:10.1016/S1040-8428(03)00093-3
Verheul HM, Jorna AS, Hoekman K et al (2000) Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 96:4216–4221
Yang L, DeBusk LM, Fukuda K et al (2004) Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6:409–421. doi:10.1016/j.ccr.2004.08.031
Yang MH, Wu MZ, Chiou SH et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295–305. doi:10.1038/ncb1691
Acknowledgments
This work was partially supported by the Taiwan Clinical Oncology Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, MH., Chang, P.MH., Chen, PM. et al. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol 135, 1783–1790 (2009). https://doi.org/10.1007/s00432-009-0625-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-009-0625-1